The company excluded people with a history of severe allergic reactions to vaccines from their SARS COV 2 RNA vaccine trial , according to Pfizer data released by the US Food and Drug Administration on Tuesday . 
Participants with a " history of severe adverse reaction associated with a vaccine and/or severe allergic reaction ( eg , anaphylaxis ) to any component of the study intervention ( s ) " were not included in the pool of 44,000 trial volunteers . 
According to the US Food and Drug Administration 's evaluation of the Pfizer data , there was a slight increase in events that may be considered allergic reactions in the vaccine group . 
The FDA â€™s independent analysis said " A slight numerical imbalance of adverse events potentially representing allergic reactions , with more participants reporting hypersensitivity related adverse events in the vaccine group ( 137 [ 0.63 % ] ) compared with the placebo group ( 111 [ 0.51 % ] ) " Some background : The UK issued new guidance on Wednesday , now advising that people with a " significant history of allergic reactions " not receive the Pfizer/Bio NTech coronavirus vaccine after two health workers who received the vaccine suffered allergic reactions . 
British health authorities are conducting an investigation into the two incidents . 
In a statement , Pfizer said " As a precautionary measure , the MHRA has issued temporary guidance to the NHS while it conducts an investigation in order to fully understand each case and its causes . 
Pfizer and Bio NTech are supporting the MHRA in the investigation . " 
Both staff members reportedly had a significant history of allergic reactions and carried adrenaline autoinjectors , according to PA Media . 
Thousands overall are believed to have been vaccinated in the UK on Tuesday . 
The FDA 's vaccine advisory group is meeting on Thursday to discuss a possible emergency use authorization of the Pfizer Bio NTech Covid 19 vaccine in the US . 
